Abstract Topics
- CAR T cell therapies in hematological malignancies
- CAR and TCR targets
- Engineered T cell therapy for solid tumors
- Non-viral vectors and transposons
- Allogeneic/universal donor cells
- Rare, autoimmune and infectious diseases as cell therapy targets
- New approaches in lymphocyte engineering
- Regulatory Perspectives and Requirements in Advanced Therapies
- Other
